Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
The flavone hispidulin, a benzodiazepine receptor ligand with positive allosteric properties, traverses the blood-brain barrier and exhibits anticonvulsive effects.
Kavvadias D
,
Sand P
,
Youdim KA
,
Qaiser MZ
,
Rice-Evans C
,
Baur R
,
Sigel E
,
Rausch WD
,
Riederer P
,
Schreier P
.
???displayArticle.abstract???
The functional characterization of hispidulin (4',5,7-trihydroxy-6-methoxyflavone), a potent benzodiazepine (BZD) receptor ligand, was initiated to determine its potential as a modulator of central nervous system activity. After chemical synthesis, hispidulin was investigated at recombinant GABA(A)/BZD receptors expressed by Xenopus laevis oocytes. Concentrations of 50 nm and higher stimulated the GABA-induced chloride currents at tested receptor subtypes (alpha(1-3,5,6)beta(2)gamma(2)S) indicating positive allosteric properties. Maximal stimulation at alpha(1)beta(2)gamma(2)S was observed with 10 microm hispidulin. In contrast to diazepam, hispidulin modulated the alpha(6)beta(2)gamma(2)S-GABA(A) receptor subtype. When fed to seizure-prone Mongolian gerbils (Meriones unguiculatus) in a model of epilepsy, hispidulin (10 mg kg(-1) body weight (BW) per day) and diazepam (2 mg kg(-1) BW per day) markedly reduced the number of animals suffering from seizures after 7 days of treatment (30 and 25% of animals in the respective treatment groups, vs 80% in the vehicle group). Permeability across the blood-brain barrier for the chemically synthesized, (14)C-labelled hispidulin was confirmed by a rat in situ perfusion model. With an uptake rate (K(in)) of 1.14 ml min(-1) g(-1), measurements approached the values obtained with highly penetrating compounds such as diazepam. Experiments with Caco-2 cells predict that orally administered hispidulin enters circulation in its intact form. At a concentration of 30 microm, the flavone crossed the monolayer without degradation as verified by the absence of glucuronidated metabolites.
Avallone,
Pharmacological profile of apigenin, a flavonoid isolated from Matricaria chamomilla.
2000, Pubmed
Avallone,
Pharmacological profile of apigenin, a flavonoid isolated from Matricaria chamomilla.
2000,
Pubmed
Bertorelli,
The Mongolian gerbil in experimental epilepsy.
1995,
Pubmed
Boileau,
The relative amount of cRNA coding for gamma2 subunits affects stimulation by benzodiazepines in GABA(A) receptors expressed in Xenopus oocytes.
2002,
Pubmed
,
Xenbase
Chulasiri,
Mutagenicity and antimutagenicity of hispidulin and hortensin, the flavonoids from Millingtonia hortensis L.
1992,
Pubmed
Egleton,
Transport of opioid peptides into the central nervous system.
1998,
Pubmed
Gil,
Effects of flavonoids on Naja naja and human recombinant synovial phospholipases A2 and inflammatory responses in mice.
1994,
Pubmed
Goutman,
Flavonoid modulation of ionic currents mediated by GABA(A) and GABA(C) receptors.
2003,
Pubmed
,
Xenbase
Hui,
Anxiolytic effect of wogonin, a benzodiazepine receptor ligand isolated from Scutellaria baicalensis Georgi.
2002,
Pubmed
,
Xenbase
Johnston,
Flavonoids: some of the wisdom of sage?
2004,
Pubmed
Kavvadias,
Constituents of sage (Salvia officinalis) with in vitro affinity to human brain benzodiazepine receptor.
2003,
Pubmed
Marder,
Molecular modeling and QSAR analysis of the interaction of flavone derivatives with the benzodiazepine binding site of the GABA(A) receptor complex.
2001,
Pubmed
Marder,
6-methylapigenin and hesperidin: new valeriana flavonoids with activity on the CNS.
2003,
Pubmed
Medina,
Neuroactive flavonoids: new ligands for the Benzodiazepine receptors.
1998,
Pubmed
Sieghart,
Subunit composition, distribution and function of GABA(A) receptor subtypes.
2002,
Pubmed
Sigel,
The effect of subunit composition of rat brain GABAA receptors on channel function.
1990,
Pubmed
,
Xenbase
Sigel,
Properties of single sodium channels translated by Xenopus oocytes after injection with messenger ribonucleic acid.
1987,
Pubmed
,
Xenbase
Sigel,
The benzodiazepine binding site of GABAA receptors.
1997,
Pubmed
Spencer,
The small intestine can both absorb and glucuronidate luminal flavonoids.
1999,
Pubmed
Takasato,
An in situ brain perfusion technique to study cerebrovascular transport in the rat.
1984,
Pubmed
Tan,
Mono- and sesquiterpenes and antifungal constituents from Artemisia species.
1999,
Pubmed
Treiman,
GABAergic mechanisms in epilepsy.
2001,
Pubmed
Viola,
Apigenin, a component of Matricaria recutita flowers, is a central benzodiazepine receptors-ligand with anxiolytic effects.
1995,
Pubmed
Youdim,
Interaction between flavonoids and the blood-brain barrier: in vitro studies.
2003,
Pubmed
Youdim,
Flavonoid permeability across an in situ model of the blood-brain barrier.
2004,
Pubmed
